Axsome Therapeutics (AXSM) EPS (Basic) Growth (1y) (2016 - 2026)
Axsome Therapeutics (AXSM) EPS (Basic) Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn | 17,151.81% |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - | - |
| 10 | Axsome Therapeutics | 12.32 Bn | 12.01 Bn | 176.48 Mn | -3.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.69% |
| Dec 31, 2025 | 63.19% |
| Sep 30, 2025 | 29.64% |
| Jun 30, 2025 | 41.82% |
| Mar 31, 2025 | 15.71% |
| Dec 31, 2024 | 28.00% |
| Sep 30, 2024 | -1.66% |
| Jun 30, 2024 | -8.41% |
| Mar 31, 2024 | -458.60% |
| Dec 31, 2023 | -44.15% |
| Sep 30, 2023 | -22.82% |
| Jun 30, 2023 | -45.10% |
| Mar 31, 2023 | 75.03% |
| Dec 31, 2022 | -61.35% |
| Sep 30, 2022 | 81.55% |
| Jun 30, 2022 | 81.76% |
| Mar 31, 2022 | -27.31% |
| Dec 31, 2021 | -15.26% |
| Sep 30, 2021 | 7.70% |
| Jun 30, 2021 | 22.47% |